These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16469015)

  • 1. Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit?
    Ockrim JL; Lalani el-N; Aslam M; Standfield N; Abel PD
    BJU Int; 2006 Mar; 97(3):498-504. PubMed ID: 16469015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal estradiol therapy for advanced prostate cancer--forward to the past?
    Ockrim JL; Lalani EN; Laniado ME; Carter SS; Abel PD
    J Urol; 2003 May; 169(5):1735-7. PubMed ID: 12686820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience.
    Kandola S; Anyamene N; Payne H; Harland S
    BJU Int; 2007 Jan; 99(1):53-5. PubMed ID: 17227492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.
    Ockrim JL; Lalani el-N; Kakkar AK; Abel PD
    J Urol; 2005 Aug; 174(2):527-33; discussion 532-3. PubMed ID: 16006886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high dose oestrogen therapy on circulating inflammatory markers.
    Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
    Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
    Ryan CJ; Harzstark AH; Rosenberg J; Lin A; Claros C; Goldfine ID; Kerner JF; Small EJ; Youngren JF
    BJU Int; 2008 Feb; 101(4):436-9. PubMed ID: 18234062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
    Prázný M; Fait T; Vrablik M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO; Genazzani AR; Samsioe G; Vukovic-Wysocki I; Seeger H
    Menopause; 2007; 14(6):978-84. PubMed ID: 17595593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
    Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
    J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy Insight: parenteral estrogen treatment for prostate cancer--a new dawn for an old therapy.
    Ockrim J; Lalani el-N; Abel P
    Nat Clin Pract Oncol; 2006 Oct; 3(10):552-63. PubMed ID: 17019433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical evaluation of hemodynamic effects of regular use of sildenafil on the human corpora cavernosa.
    Natali A; Bartolini M; Lucarini S; Vignolini G; Nelli F; Menchi I
    Urol Int; 2009; 82(1):53-60. PubMed ID: 19172098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.
    Schwenke C; Ubrig B; Thürmann P; Eggersmann C; Roth S
    J Urol; 2009 Mar; 181(3):1098-103. PubMed ID: 19150092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
    de Carvalho MN; Nobre F; Mendes MC; Dos Reis RM; Ferriani RA; Silva de Sá MF
    Blood Press Monit; 2008 Oct; 13(5):277-83. PubMed ID: 18799953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
    Wadhwa VK; Weston R; Mistry R; Parr NJ
    BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of vascular access (VA) by color Doppler ultrasonography (CDU). Comparison between delta-H and CDU methods in measuring VA blood flow rate].
    Roca-Tey R; Rivas A; Samon R; Ibrik O; Viladoms J
    Nefrologia; 2005; 25(6):678-83. PubMed ID: 16514909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
    La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
    Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women.
    Sherwood A; Bower JK; McFetridge-Durdle J; Blumenthal JA; Newby LK; Hinderliter AL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1782-7. PubMed ID: 17541023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.